Reuters logo
BRIEF-FDA Grants Genentech’S Avastin Full Approval For Most Aggressive Form Of Brain Cancer
December 5, 2017 / 10:47 PM / 12 days ago

BRIEF-FDA Grants Genentech’S Avastin Full Approval For Most Aggressive Form Of Brain Cancer

Dec 5 (Reuters) - Roche Holding AG:

* FDA GRANTS GENENTECH’S AVASTIN FULL APPROVAL FOR MOST AGGRESSIVE FORM OF BRAIN CANCER

* GENENTECH - CONVERSION TO FULL APPROVAL WAS BASED ON TOTALITY OF EVIDENCE OF AVASTIN IN GLIOBLASTOMA, INCLUDING DATA FROM PHASE III EORTC 26101 STUDY Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below